Affiliations 

  • 1 Department of Pharmacology, Amrita School of Pharmacy, AIMS Health Science Campus, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India
  • 2 Department of Pharmacognosy, Acharya & B.M.Reddy College of Pharmacy, Bangalore, Karnataka, India
  • 3 Department of Pharmacy Practice, International Medical University, Kualalampur, Malaysia
  • 4 Department of Pharmacology, Grace College of Pharmacy, Palakkad, Kerala, India
  • 5 Department of Pharmacognosy, Government Medical College, Thiruvananthapuram, Kerala, India
Bioinformation, 2014;10(9):580-5.
PMID: 25352726 DOI: 10.6026/97320630010580

Abstract

Kinase Suppressor of Ras (KSR) is a molecular scaffold that interacts with the core kinase components of the ERK cascade, Raf, MEK, ERK to provide spatial and temporal regulation of Ras-dependent ERK cascade signaling. Interruption of this mechanism can have a high influence in inhibiting the downstream signaling of the mutated tyrosine kinase receptor kinase upon ligand binding. Still none of the studies targeted to prevent the binding of Raf, MEK binding on kinase suppressor of RAS. In that perspective the cysteine rich C1 domain of scaffold proteins kinase suppressor of Ras-1 was targeted rather than its ATP binding site with small ligand molecules like flavones and anthocyanidins and analyzed through insilico docking studies. The binding energy evaluation shows the importance of hydroxyl groups at various positions on the flavone and anthocyanidin nucleus. Over all binding interaction shows these ligands occupied the potential sites of cysteine rich C1 domain of scaffold protein KSR.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.